tiprankstipranks
Trending News
More News >
Oruka Therapeutics (ORKA)
NASDAQ:ORKA
US Market

Oruka Therapeutics (ORKA) Income Statement

Compare
723 Followers

Oruka Therapeutics Income Statement

Last quarter (Q3 2025), Oruka Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Oruka Therapeutics's net income was $-30.28M. See Oruka Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -27.00K$ -114.00K$ -91.00K$ -93.00K$ -89.00K
Operating Expenses
$ 88.10M$ 9.73M$ 19.24M$ 9.67M$ 5.72M
Depreciation and Amortization
$ 27.00K$ 114.00K$ 91.00K$ 93.00K$ 89.00K
EBITDA
$ -82.23M$ -9.81M$ -19.23M$ -9.64M$ -5.55M
Operating Income
$ -88.12M$ -9.84M$ -19.34M$ -9.77M$ -5.81M
Other Income/Expenses
$ 4.40M$ -85.00K$ 13.00K$ 19.00K$ 165.00K
Pretax Income
$ -83.72M$ -9.93M$ -19.32M$ -9.75M$ -5.65M
Net Income
$ -83.72M$ -9.93M$ -19.32M$ -9.74M$ -5.48M
Per Share Metrics
Basic EPS
$ -4.99$ -8.27$ -16.68$ -8.40$ -49.79
Diluted EPS
$ -4.99$ -8.27$ -16.68$ -8.40$ -49.79
Weighted Average Shares Outstanding
16.79M 14.41M 13.90M 4.71M 110.10K
Weighted Average Shares Outstanding (Diluted)
16.79M 14.41M 13.90M 4.71M 110.10K
Currency in USD

Oruka Therapeutics Earnings and Revenue History